Remote Evaluation in Patients With Multiple Sclerosis

March 6, 2024 updated by: Burcu Talu, Inonu University

Remote Reliability Of 30 Seconds Sit And Stand Test In Patients With Multiple Sclerosis

This study aimed to demonstrate the remote reliability of the 30-second sit-to-stand test in patients with multiple sclerosis.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The population of the research will be participants with multiple sclerosis. The 30-second sit-to-stand test will be performed in the participant's home environment. . Patients will be instructed to cross their arms over their chest and complete as many standing cycles as possible in 30 seconds, standing until fully upright and then sitting until the hips touch the chair without the assistance of the hands. Inter-rater reliability will be assessed by two different raters in the same video interview. In contrast, intra-rater reliability will be evaluated by analyzing the number of repetitions recorded by the same rater in two different video interviews conducted 24-28 hours apart.

Study Type

Observational

Enrollment (Estimated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

multiple sclerosis patients

Description

Inclusion Criteria:

  • Having been diagnosed with MS according to the McDonald criteria by a neurologist
  • having and being able to use a device with Internet access (e.g. smartphone, computer or tablet)
  • having EDSS between 1.5 and 6.5,
  • being between the ages of 18-65.

Exclusion Criteria:

  • Patients who have had a recurrence of the disease in the last 30 days,
  • have an additional health problem (orthopedic, neurological, internal or cardiorespiratory) that prevents standing/walking,
  • do not agree to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 second sit and stand test
Time Frame: 24-48 hours
The 30-second sit-to-stand test is a test used to evaluate lower extremity muscle strength, balance and walking functions.
24-48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Inonu University

Investigators

  • Study Director: Burcu talu, Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 11, 2024

Primary Completion (Estimated)

June 24, 2024

Study Completion (Estimated)

June 29, 2024

Study Registration Dates

First Submitted

March 6, 2024

First Submitted That Met QC Criteria

March 6, 2024

First Posted (Actual)

March 13, 2024

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 6, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024/5558

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study data can be shared with other researchers if desired

IPD Sharing Time Frame

After the study was published

IPD Sharing Access Criteria

If requested from the authors, it can be shared with researchers at the authors' discretion.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on 30 second sit and stand test

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe